Clinical Trials Logo

Clinical Trial Summary

This trial will compare two strategies for patients with Heart Failure, Left Ventricular systolic dysfunction, and intermediate QRS durations. The control group is conventional CRT. The experimental group is LVendo CRT


Clinical Trial Description

Patients randomized to the Conventional CRT will receive a CRT device with or without ICD. Device implantation will be performed within 10 working days of randomization.

Patients randomized to LV endocardial CRT will receive a CRT device with or without ICD, placed in the same time frame and will have RA and RV leads implanted as the conventional CRT group. The device will be implanted in a facility that has the capacity to perform trans-atrial septal puncture with ultrasound guidance. The LV lead will be placed using a trans-atrial septal approach using a specially designed puncture tools and LVendo delivery tool kits specifically designed for this study ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02757976
Study type Interventional
Source Lawson Health Research Institute
Contact
Status Terminated
Phase N/A
Start date March 8, 2018
Completion date June 20, 2019